JAN 14, 2021 6:00 AM PST

Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics

WRITTEN BY: Tara Fernandez

Only 10 percent of icebergs are visible on the water's surface; the remaining 90 percent remains submerged. Similarly, UCLA researchers have found that there could be more to prostate tumors than what is visible in diagnostic images. A study published in the Journal of Urology highlights how magnetic resonance imaging (MRI), commonly used to visualize prostate tumors, often does not paint an accurate picture of tumor size. This disconnect in information can lead to inadequate cancer interventions.

MRI uses powerful magnetic forces and radiofrequency waves to construct incredibly detailed 3-dimensional visual representations of internal body structures such as organs, bones, and tissues. In some techniques, the addition of a contrast medium helps enhance the clarity and resolution of the images generated. 

MRI-based procedures are standard practice in the diagnosis and management of prostate cancer. It allows oncologists to analyze the tumor's physical characteristics, which informs which clinical intervention would likely be most effective for eliminating the cancerous tissue—from cryotherapy to laser ablation.

Scientists at the UCLA Jonsson Comprehensive Cancer Center found that this approach might not be as effective as once thought. In a study of over 400 participants, the found that the underestimation of tumor size was particularly pronounced for smaller masses, which had low PI-RADS scores (a scoring system from 1 to 5 used to determine the clinical significance of MRI images of the prostate). To maximize the chances of success, the MRI size measurements and PI-RADS scores must line up, allowing physicians to discern the cancerous tissues from the normal, healthy tissues that border it.

Prostate cancer is the most common cancer in men in the United States. Around 60 percent of cases are diagnosed in men over 65. By improving the ability to differentiate between healthy and malignant tissues, the authors anticipate more successful treatments and a reduction in the number of lives lost from the disease.

 

Source: Journal of Urology.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
DEC 31, 2020
Clinical & Molecular DX
Silent Mice Drive Autism Gene Discovery
DEC 31, 2020
Silent Mice Drive Autism Gene Discovery
Around 1 in 54 children in the U.S. are diagnosed with autism spectrum disorder, or ASD, a broad range of conditions tha ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
JAN 14, 2021
Cardiology
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
JAN 14, 2021
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
The everyday tracking of health has become far easier these days with the advent of fitness watches and other technology ...
JAN 12, 2021
Cell & Molecular Biology
Hyperactive Mitochondria Can Fuel Brain Tumors
JAN 12, 2021
Hyperactive Mitochondria Can Fuel Brain Tumors
The most common and deadly form of brain cancer is known as glioblastoma; the median survival time for patients is only ...
APR 29, 2021
Clinical & Molecular DX
Can We Diagnose Disease Based on How "Sticky" Cells Are?
APR 29, 2021
Can We Diagnose Disease Based on How "Sticky" Cells Are?
How “sticky” cells are, or their viscosity, holds a wealth of information about their health and functionali ...
Loading Comments...